Sinovac Biotech Ltd. girma ( Chinese , Nasdaq ) wani kamfani ne na likitancin halittu na kasar Sin wanda ke mai da hankali kan bincike, haɓakawa, ƙira, da kuma tallata rigakafin da ke ba da kariya ga cututtukan ɗan adam . Kamfanin yana zaune ne a gundumar Haidian, Beijing a kasar Sin. An jera kamfanin akan NASDAQ amma musayar ta dakatar da cinikin Sinovac a watan Fabrairun 2019 saboda yakin wakili. Kamfanin ya fuskanci binciken cin hanci a China. Maganin sayar da Sinovac sun haɗa da CoronaVac ( alurar rigakafin COVID-19 ), Inlive ( alurar rigakafin Enterovirus 71 ), Anflu ( alurar rigakafin mura ), Healive (alurar rigakafin hanta A ), maganin varicella da rigakafin mumps . CoronaVac kwayar cuta ce da ba a kunna ta ba ta COVID-19 wacce Sinovac ta kirkira. Ya kasance a cikin gwajin asibiti na Phase III a Brazil, Chile, Indonesia, Philippines, da Turkiyya . Ya dogara da fasahar gargajiya irin ta BBIBP-CorV da BBV152, in ba haka ba an san su da allurar rigakafin cutar COVID-19 da ba a kunna ba a cikin gwaji na Mataki na III. CoronaVac baya buƙatar daskarewa, kuma duka alluran rigakafi da kayan da za a ƙirƙira sabbin allurai ana iya jigilar su kuma a sanya su cikin firiji a 2-8 °C (36-46 °F), yanayin yanayin da ake kiyaye rigakafin mura.